Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer. Imamura Y, Kato T, Nomata Y, Okado S, et al. Anticancer Res 2024;44:3451-3461.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Imamura Y, Kato T, Nomata Y, Okado S, et al. Efficacy of Immune Checkpoint Inhibitors in Postoperative Recurrence of Wild-type EGFR Non-Small Cell Lung Cancer. Anticancer Res 2024;44:3451-3461.
PMID: 39060057